Now FDA approved to treat excessive daytime sleepiness (EDS) in children 6 years of age and older with narcolepsy.

EDS in Children 6-17 Years Old

Results With WAKIX in the Clinical Trial of Children 6-17 Years Old

Significantly reduced excessive daytime sleepiness (EDS) in patients 6-17 years old with narcolepsy compared with placebo

EDS Results
Side Effects

EDS Results

WAKIX significantly reduced excessive daytime sleepiness (EDS) compared with placebo

WAKIX was studied for the treatment of EDS in a clinical trial of 110 patients (aged 6-17 years) with narcolepsy.

WAKIX was compared with placebo (sugar pill) using the Pediatric Daytime Sleepiness Scale (PDSS) questionnaire.

This questionnaire uses an overall score to measure excessive daytime sleepiness by asking 8 questions about how often one falls asleep or gets drowsy during the day in situations such as:

Falling asleep while reading icon

Homework

Falling asleep in the classroom icon

Classroom

In this 8-week clinical trial:

  • 72 patients were treated with WAKIX, and 38 patients received placebo.
  • 90 of the patients in the trial had narcolepsy with cataplexy, and 20 patients had narcolepsy without cataplexy.

At the end of the trial…

  • Reduced sleepiness icon

    Scores on the PDSS were significantly improved for patients taking WAKIX compared with placebo

    This means patients taking WAKIX reported falling asleep or getting drowsy less often during the day compared with patients who took placebo.

  • Everyone responds to medication differently. Individual responses varied in the clinical trial.

Side Effects

WAKIX side effects in the clinical trial of children 6-17 years old

In the 8-week clinical trial of 110 patients (aged 6-17 years) with narcolepsy, the most common side effects of WAKIX were headache and insomnia.

Side effects that occurred in at least 5% of patients treated with WAKIX and more frequently than placebo

Table showing side effects of WAKIX in the clinical trial in children 6-17 years oldTable showing side effects of WAKIX in clinical trials

n indicates the number of patients who were treated with WAKIX.

Overall, the side effects seen in the clinical trial of patients aged 6-17 years with narcolepsy were similar to those seen in adult clinical trials.

In the clinical trials of adults with narcolepsy:

  • The most common side effects of WAKIX were insomnia, nausea, and anxiety.
  • Other side effects of WAKIX included headache, upper respiratory tract infection, musculoskeletal pain, increased heart rate, hallucinations, irritability, abdominal pain, sleep disturbance, and decreased appetite.
  • Talk bubble icon

    These are not all the possible side effects of WAKIX. Tell your healthcare provider about any side effect that is bothersome or that does not go away.